#Act4 LabAnimals Dr. Aysha Akhtar, double board-certified neurologist, is on a mission to show how treating animals with kindness also benefits people in a “win-win” situation for all. Dr. Aysha Akhtar is leading a movement to end animal experiments 10 October 2020
#Act4 LabAnimals Pascal Descargues, CEO at Genoskin explains how Genoskin’s human skin models are created, discusses how these models can impact the drug development process and elaborates on how they are helping to develop therapeutic and vaccine strategies against COVID-19. Harnessing human skin models for drug development 23 September 2020
#Act4 LabAnimals Tens of millions of animals are used annually in the United States to test drugs, cosmetics, and other household items. Dozens of species are used in experiments, with the majority of them having been bred for the purpose. Let's end animal testing in 2020 16 March 2020 Opinion
#Act4 LabAnimals The U.S. National Toxicology Program (NTP) Board of Scientific Counselors (BSC) met on 21 February to discuss the critical issues of making toxicology testing more human relevant, as well as micro- and nanoplastics in our environment, among other topics. US National Toxicology Program: more focus on human-relevant non-animal approaches for safety testing 6 March 2020
#Act4 LabAnimals The legislation would end safety testing of cosmetic products on animals and prohibit the sale of products developed using animal testing. US is one step closer to ending animal testing for cosmetics 19 November 2019
#Act4 LabAnimals Today, U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler signed a directive to prioritize efforts to reduce animal testing. US EPA commits to concrete measures, milestones and timelines to reduce animal testing 10 September 2019
